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Abstract
 
Natural killer (NK) cells and dendritic cells (DCs) are two distinct cell types of innate immu-
nity. It is known that the in vitro interaction of human NK cells with autologous DCs results
in DC lysis. Here we show that contact-dependent interactions between activated human NK
cells and immature DCs (iDCs) provides a “control switch” for the immune system. At low
NK/DC ratios, this interaction dramatically amplifies DC responses, whereas at high ratios it
completely turns off their responses. Specifically, culture of activated human NK cells with
iDCs, at low NK/DC ratios (1:5), led to exponential increases in DC cytokine production,
which were completely dependent on cell-to-cell contact. DC maturation was also driven by
cognate interactions with NK cells and maturation was dependent on endogenously produced
TNF-
 
 
 
 in the culture. At slightly higher NK/DC ratios (5:1), inhibition of DC functions was
the dominant feature due to potent killing by the autologous NK cells. Resting NK cells also
stimulated autologous DC maturation in a TNF-
 
 
 
/contact-dependent manner, however, in-
creasing the NK/DC ratio only led to an enhancement of this effect.
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Introduction
 
The innate immune response faces two mutually exclusive
priorities. One is to respond to pathogenic threats with
maximum speed and potency to initiate the immune re-
sponse and mount the first line of defense against an infec-
tion. Competing with this goal is the requirement of
controlling the initiation/amplification process to avoid
overshoot and responses to benign stimuli. Failure to find a
compromise between these two extremes can result in un-
controlled infection, for the former, or immune-mediated
pathologies (e.g., septic shock or auto-immunity), for the
latter. Cooperation between distinct immune cells and re-
ciprocal coordination of their responses provides a robust
mechanism for regulating the initiation and amplification of
an immune response. NK cells and DCs are two specialized
cell types of innate immunity and both act as liaisons be-
tween innate and antigen-specific responses (1, 2). DCs are
considered sentinels of the immune system because of their
role as initiators of both innate and antigen-specific immu-
nity (1, 3). NK cells are lymphocytes active in innate re-
sponses against viruses, bacteria, and tumors, due to their
potent cytotoxic activity and rapid production of cytokines
(4). Although NK cells are part of innate immunity, they
share many phenotypic and functional features with T cells
(5–7). T cells cooperate with DCs in the initiation/amplifi-
cation of antigen-specific responses (1, 3). We reasoned
that NK cells may perform an analogous function during
the initial phase of an immune response before activated T
cells are generated. To address this hypothesis we devel-
oped an in vitro model to dissect the potential interactions
between autologous NK cells and immature DCs (iDCs)
 
*
 
in the presence or absence of limiting concentrations of a
bacterial stimulus (LPS). Using this culture system we have
uncovered a new amplification/attenuation mechanism rel-
evant to the regulation of innate immune responses in vivo.
 
Materials and Methods
 
Antibodies and Blocking Reagents.
 
Antibodies used for flow
cytometry were: anti-CD86-FITC, -CD83-PE, -HLA-DR-
PerCP, -CD69-FITC or -PE, -CD25-FITC, -CD3-FITC or
-PE, -CD19-FITC, -CD14-FITC, -CD1a-FITC, -CD80-FITC
or -PE, and -CD56-FITC or -PE (Becton Dickinson). Staining
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Abbreviation used in this paper:
 
 iDC, immature DC. 
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of cells was performed according to standard protocols and flow
cytometric analysis was performed using a FACSCalibur™ cy-
tometer. Antibodies used for magnetic activated cell sorting
(MACS
 
®
 
) and subset purifications were: anti-CD3, anti-CD14,
and anti-CD19 (Becton Dickinson). Blocking/neutralizing re-
agents used in different experiments were: anti–IFN-
 
 
 
 (mAb
MMHA-1 and sheep polyclonal anti–human; Ancell); anti–IFN-
 
 
 
(sheep polyclonal anti–human; Biosource International); r-hu-
fas-ligand/Fc chimera (CD178; R&D Systems); hu-CTLA-4
muIg fusion protein (CD152; Ancell); anti–LFA-1 (CD11a, mAb
G43–25B; Becton Dickinson); anti–TNF-
 
 
 
 (mAb B154.2); anti–
IL-12 p40 (mAb C8.6); and anti–IFN-
 
 
 
 (mAb B133.3) (all pro-
vided by G. Trinchieri, Schering Plough Corp., Lyon, France);
humanized anti-CD40 (mAb 5H7; supplied by K. Chu, Chiron
Corp., Emeryville, CA). All neutralizing antibodies and reagents
were used at, at least, two different concentrations which were
equal to and exceeded the manufacturers’ instructions or their
previously published levels for neutralization.
 
Cell Preparations and Cultures.
 
PBMCs were prepared from
healthy blood donors (buffy coats or lab volunteers) by separation
on a Ficoll-Hypaque gradient. iDCs were generated as described
by Sallusto and Lanzavecchia (8). Briefly, highly purified (
 
 
 
98%)
monocyte populations were obtained from PBMCs by MACS
 
®
 
(Miltenyi Biotec), using a one step positive selection of CD14
 
 
 
cells with anti-CD14–coated magnetic microbeads (Miltenyi
Biotec). The monocytes were then cultured for 5–6 d in RPMI
1640 medium (Life Technologies) supplemented with 10% FCS
(Hyclone); IL-4 (10% of supernatant from an IL-4–secreting cell
line, provided by A. Lanzavecchia, Institute for Research in Bio-
medicine, Bellinzona, Switzerland) and 50 ng/ml of GM-CSF
(Leucomax
 
®
 
). After culture the iDC populations were routinely
checked for CD1a and CD80 expression and their lack of CD14
expression. Purified (85–95% CD56
 
 
 
/CD3
 
 
 
), resting NK cells
were obtained from PBMCs by MACS
 
®
 
 (Miltenyi Biotec) using
a two step protocol: PBMCs were first incubated with purified
anti-CD3, anti-CD14, and anti-CD19 mAb’s (Becton Dickin-
son) for 30 min followed by negative selection with goat anti–
mouse microbeads (Miltenyi Biotec). After which the NK cells
(which contained
 
  
 
1% contamination with CD3
 
 
 
, CD19
 
 
 
, and
CD14
 
 
 
 cells but between 5–15% lineage negative cells) were fro-
zen in 90% FCS; 10% DMSO for 5–6 d. Prior to their use in ex-
periments with cultured, autologous iDCs, they were gently
thawed, washed, and resuspended in RPMI 1640/10% FCS me-
dium (RPMIc). Purified (99% CD56
 
 
 
/CD3
 
 
 
), activated NK
cells were obtained using the method of Perussia et al. with slight
modification (9). Briefly, PBMCs were cultured with the irradi-
ated (5,000 rads) EBV-transformed B cell line, RPMI 8866, in
24-well plates at a ratio of 5:1 (PBMC:8866). For experiments
with buffy coats the PBMCs were cultured for 5–6 d, whereas for
PBMCs from lab volunteers who donated blood twice (first for
NK cell cultures and then for iDC cultures), they were cultured
for 8 d under the published conditions (9). After culture, purified
NK cells were obtained by negative selection by MACS
 
®
 
 (Mil-
tenyi Biotec) as described above for resting NK cells.
 
NK–iDC Cultures.
 
The specific details of the different exper-
iments are described in the figure legends. In general, activated/
cultured or resting NK cells were added to autologous iDCs at
the ratios (NK/DC) indicated and the cells were cocultured in
RPMIc medium for 24–48 h in the presence or absence of the
indicated doses of LPS (Sigma-Aldrich). Prior to coculture, the
iDCs were removed from their GM-CSF/IL-4 containing me-
dium by washing with RPMI 1640 medium. Control experi-
ments comparing NK activation or iDC maturation in the pres-
 
ence or absence of the DC culture medium (GM-CSF/IL-4)
showed no differences.
 
Measurement of Cytokine Production.
 
Cytokine production was
quantified in culture supernatants by specific sandwich ELISA’s
for TNF-
 
 
 
 (capture/secondary; mAb’s B154.9/B154.7), IL-12
p40 (mAb’s C11.79/C8.6), and IL-10 (mAb’s JES3–907/JES3–
12G8). The antibodies for TNF-
 
 
 
 and IL-12 p40 ELISA were
provided by G. Trinchieri and those for IL-10 were obtained
from BD PharMingen. Recombinant standards for all assays were
obtained from R&D Systems.
 
Cell-mediated Cytotoxicity Assays.
 
NK cell killing of iDCs or
K562 was determined using standard 4-h chromium release as-
says and a flow cytometric assay for NK cell killing developed by
McGinnes et al. with slight modifications (10). Briefly, iDCs or
K562 cells were loaded with 5 
 
 
 
M CFDA SE for 5 or 15 min,
respectively, and incubated in 96-well plates (U-bottom; Co-
star) with activated/cultured NK cells at the indicated NK/target
ratios. After the indicated times (4 or 24 h) each sample was re-
suspended in a final volume of 600 
 
 
 
l of PBS, to which 50 
 
 
 
l of
Flow Check fluorospheres (Beckman Coulter) were added. Us-
ing the cytometer, a fixed number (700) of fluorescent beads was
acquired and the percentage of killing was calculated using the
following equation: (the number of CFDA SE
 
 
 
 cells acquired in
the control without NK cells) 
 
  
 
(the number of CFDA SE
 
 
 
cells in the sample)/(the sample of CFDA SE
 
 
 
 cells in the con-
trol) 
 
  
 
100. Comparison of 4-h chromium release assays with
the 4-h flow cytometric procedure revealed minor differences
with the flow cytometric technique being more sensitive (un-
published data).
 
NK Cell Conjugate Formation Assays.
 
NK–iDC or NK-K562
conjugates were detected by flow cytometry using NK cells la-
beled with CFDA SE (Molecular Probes) and iDCs or K562 la-
beled with SNARF-1 (Molecular Probes). After dye loading (NK
cells and K562, 15 min at 37
 
 
 
C with 5 
 
 
 
M of CFDA SE or 2
 
 
 
M SNARF-1, respectively, and iDCs, 5 min at 37
 
 
 
C with 2
 
 
 
M of SNARF-1) the cells were washed and incubated alone or
together (NK–K562 or NK–iDC) at the indicated ratios for 30
min at 37
 
 
 
C. Prior to incubation the cells were centrifuged at 200 
 
g
 
for 3 min at room temperature. The percentage of conjugates
formed was calculated on a FACSCalibur™ cytometer (Becton
Dickinson) by gating on the FL3
 
 
 
 cells (SNARF-1/iDCs or
K562) and determining the percent of this population also posi-
tive for FL1 (CFDA SE/NK).
 
Results
 
Contact-dependent and Reciprocal Activation of NK Cells and
iDCs.
 
We began our study by investigating the interac-
tions between autologous iDCs and resting NK cells. These
initial experiments demonstrated that both cell types become
activated after coculture for 18–48 h. The iDCs showed ev-
idence of maturation as determined by their increased ex-
pression of CD86 (Fig. 1 A), HLA-DR and CD83 (data not
shown) which was augmented by the addition of increasing
concentrations of LPS. The NK effect was dependent on
cell-to-cell contact as separation of the cells by a permeable
membrane (trans-well) completely abrogated DC matura-
tion. Addition of a neutralizing antibody against TNF-
 
 
 
 also
blocked NK-mediated maturation of the iDC (Fig. 1 B). By
contrast, the addition of other blocking reagents specific
for IL-12, IFN-
 
 
 
, IFN-
 
 
 
, IFN-
 
 
 
, fas (CD95), ICAM-3 
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(CD50), CD40L (CD154), CD80, CD86, and LFA-1
(CD11a) to the cultures did not inhibit maturation (data not
shown). Raising the NK/DC ratio consistently led to in-
creased maturation of the DCs (Fig. 1 C).
Under the same conditions, NK cells were also stimu-
lated by the iDCs and upregulated their expression of the
activation markers CD69 (Fig. 1 D) and CD25 (data not
shown), however, the addition of LPS to the cultures did
not enhance this activation. Unlike DC maturation, in-
creasing the NK/DC ratio in favor of the NK cells led to
decreased expression of these activation markers, and at the
highest NK/DC ratios tested, the expression of CD69 re-
turned to baseline. The activation of NK cells observed in
these cultures was dependent on contact with the iDCs
(Fig. 1 E–G). The blocking reagents used in the previous
experiments on DC maturation also had no effect on iDC-
Figure 1. Reciprocal stimula-
tion of resting NK cells and au-
tologous iDCs. Cultured iDCs
and resting, purified NK cells
were incubated alone or in com-
bination for 18 h (E–G) or 48 h
(A–D). After culture the cells
were analyzed by flow cytometry
for the expression of CD86
(DCs; A–C), CD69 (NK; D) or
CD69 and CD25 (NK; E–G).
Specific analysis of NK cell or
DC subsets was achieved by a
combination of gating on for-
ward versus side scatter differ-
ences and staining with antibod-
ies for CD56 (NK) or CD86
(DC). (A) iDCs were incubated
alone ( ) or with NK cells ( )
at a ratio of 5:1 (NK/DC) in the
presence of the indicated doses
of LPS. The percentage of
CD86bright DC was determined
by specific gating. (B) The representative experiment shown was performed in the presence of 6.25 ng/ml of LPS and the iDCs were incubated alone
(gray bar); with NK cells at a 5:1 (NK/DC) ratio (black bar); with NK cells (5:1) plus 10  g/ml of a neutralizing antibody for TNF-  (white bar); or
with NK cells (5:1) but separated in trans-wells (striped bar). Changes in DC maturation were determined by measuring CD86 mean fluorescence inten-
sity (MFI). (C) iDCs were incubated alone (DCs) or with NK cells at the indicated ratios (NK/DC) in the presence ( ) or absence ( ) of 6.25 ng/ml of
LPS. DC maturation was determined as in A. (D) NK cells were incubated for 48 h either alone (NK) or with iDCs at the indicated ratios (NK/DC) in
the presence ( ) or absence ( ) of 10 ng/ml of LPS. NK cell activation was determined by the percentage of cells expressing CD69. (E–G) Flow cytom-
etry dot plots from a representative experiment measuring NK cell activation marker expression (CD69 and CD25). NK cells were incubated for 18 h:
alone (E), with iDCs at an NK/DC ratio of 1:5 (F), or with iDCs (NK/DC, 1:5), but separated in trans-wells (G).
Figure 2. Activated/cultured NK cell–mediated ampli-
fication/inhibition of DC cytokine production. Results are
presented on log scales. Cultured iDCs were incubated
alone or with cultured/purified NK cells for 24 h (A and
B) or 48 h (C–E) in the presence or absence of the indi-
cated concentrations of LPS. After culture the supernatants
were removed and analyzed by ELISA for TNF-  or IL-12
p40. (A) TNF-  production was measured in the superna-
tants from cultures of: DCs alone (gray bars); NK DC (1:5)
(black bars). LPS concentrations used were: 0, 10, and 1,000
ng/ml (DCs alone only). (B) Contact-dependent stimula-
tion of iDC TNF-  production by NK cells was tested
under the following conditions: DCs alone (gray bars);
NK DC (1:5) (black bars); NK/DC (1:5) trans-wells
(striped bars). LPS concentrations used were: 10 ng/ml
(donor 1) and 20 ng/ml (donor 2). (C and D) Effect of in-
creasing the NK/DC ratio (DCs alone; NK:DC-1:5; 1:1;
5:1) on (C) TNF-  and (D) IL-12 p40 production. LPS
concentrations used were: 0 ng/ml ( ); 20 ng/ml ( ); 50
ng/ml ( ); and 1,000 ng/ml-LPS ( ) (DCs alone only).
(E) The effect of neutralizing IFN-  production was tested
under the following conditions: DCs alone (gray bars);
NK DC (1:5) (black bars); NK DC (1:5) and 10  g/ml
of blocking anti–IFN-  mAb (stippled bars). LPS concen-
trations used were: 0 ng/ml (NO LPS) and 20 ng/ml
(LPS 20). 
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mediated NK cell activation, and neither did a neutralizing
antibody to TNF-
 
 
 
 (data not shown). Thus, contact-depen-
dent interactions between NK cells and iDCs could pro-
vide a novel positive feedback loop for the innate immune
response which is reciprocally regulated by the number of
NK–DC encounters.
 
Stimulation/Inhibition of iDC Functions by Activated NK
Cells.
 
Two previous studies have shown that both resting
and activated NK cells partially kill autologous DCs, as
measured by 3–4-h chromium release assays using high
NK/DC ratios (11, 12). However, in our long-term cul-
tures (24–48 h) the NK cells stimulated the iDCs rather
than lysing them. Based on these conflicting results, we ex-
amined in more detail the apparent stimulation of iDCs af-
ter contact with NK cells. We reasoned that activated NK
cells would be more useful for these experiments because
(i) an encounter in vivo between NK cells that normally
traffic in the blood (4) and iDCs which reside in the tissues
(1, 3), should only occur when both cells are activated; (ii)
activated NK cells mediate more potent lysis of iDCs (11–
13), thereby allowing for a more rigorous examination of a
potential cytotoxic effect; and (iii) the number of NK cells
obtained after short-term in vitro culture would be far
greater providing more cells for analysis (9).
The DC maturation induced by resting NK cells we ob-
served was dependent on endogenous TNF-
 
 
 
 production.
Furthermore, TNF-
 
 
 
 and other proinflammatory cyto-
kines are important amplifiers of immune responses (14).
Therefore, we used TNF-
 
 
 
 production as a readout for
DC stimulation in our culture system. Culturing activated
NK cells with DCs at low NK/DC ratios (1:5) led to in-
creases in TNF-
 
 
 
 production, which were augmented dra-
matically by the addition of suboptimal doses (10 ng/ml) of
LPS (Fig. 2 A). The increased TNF-
 
 
 
 production was de-
pendent on cell-to-cell contact because when the two cell
types were separated in trans-wells, no stimulation was ob-
served (Fig. 2 B). In separate experiments we observed this
NK-stimulatory effect on TNF-
 
 
 
 production at NK/DC
ratios as low as 1:20 and 1:40 (data not shown). Raising the
NK/DC ratio to 5:1 changes the interaction from one of
potent DC stimulation to that of complete inhibition in the
presence or absence of LPS (Fig. 2 C). An identical pattern
is seen for IL-12 p40 production (Fig. 2 D). No IL-10 pro-
duction in the cultures was detected under any of the con-
ditions tested (data not shown). The massive production of
TNF-
 
 
 
 in the cultures at the lowest ratios was mediated
primarily by DCs in the culture due to the low number of
NK cells (2 
 
 
 
 10
 
4
 
 cells per well) used in these experiments.
In addition, efforts to stimulate NK cells directly with opti-
mal doses of anti-CD16, rIL-2, rIL-12, and PMA/ionomy-
cin alone or in combination induced only moderate (
 
 
 
500
pg/ml) TNF-
 
 
 
 production by the NK cells alone which
were present at 2 
 
 
 
 10
 
5
 
 cells per well (data not shown).
Blocking reagents for CD80, CD86, CD154, CD95,
CD11a, CD50, or IL-12, had no effect on the NK cell–
induced TNF-
 
 
 
 or IL-12 p40 production, whereas a neu-
tralizing antibody for IFN-
 
 
 
 while not affecting TNF-
 
 
 
production partially blocked (
 
 
 
20%) IL-12 p40 production
induced by the NK cells (Fig. 2 E). This partial inhibition is
consistent with numerous previous reports demonstrating a
central role for an IL-12/IFN-
 
 
 
 positive feedback loop ac-
tive between NK cells and IL-12–producing cells (15–17).
Clearly, however, this well-described cytokine cross-talk
mechanism is secondary to the contact-dependent activa-
tion of DCs by NK cells described here. Taken together
Figure 3. Activated/cultured NK cell–mediated death/survival of DCs
and NK–DC conjugate formation. NK cell mediated killing/survival of
CFDA.SE-loaded iDCs (A) and K562 cells (B) was measured by flow cy-
tometry over 4 h ( ) or 24 h ( ) at the indicated NK/DC ratios as de-
scribed in Materials and Methods. Results are presented as percentage of
specific lysis   SEM (n   3 independent experiments). NK–DC (C–E) or
NK–K562 (F–H) conjugate formation was measured by flow cytometry,
at the following ratios (NK/DC or NK/K562): 1:5 (C and F); 1:1 (D and
G); and 5:1 (E and H). Snarf-1 (FL3)-labeled iDCs or K562 cells were in-
cubated (30 min) with CFDA.SE (FL1)-labeled NK cells at the different
ratios. The percentage of conjugates formed (top right quadrant) was cal-
culated by determining the percentage of FL3  (Snarf-1) events which
were also positive for FL1 (CFDA.SE). The results are representative of
four experiments performed with activated NK cells. Resting NK cells
also readily formed conjugates with autologous iDCs (data not shown). 
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these results indicate that novel mechanisms control cog-
nate interactions between NK cells and DCs and that NK–
DC contact has the potential to serve as an important con-
trol switch for both amplifying and attenuating innate
immune responses in vivo.
We next tested directly whether NK cell killing was ac-
tive in our system using both short-term (4-h) chromium
release assays (data not shown) and a flow cytometric assay
which allowed us to follow the survival of the autologous
iDCs in the presence of NK cells over longer periods (Fig.
3). The results demonstrate that NK cells kill autologous
iDCs (Fig. 3 A) at all NK/DC ratios tested after 4 h and the
level of killing is similar to the lysis of K562 cells over the
same time (Fig. 3 B). After 24 h, however, the presence of
NK cells led to completely divergent effects on the DCs. At
the 5:1 (NK/DC) ratio, NK cell–mediated destruction of
the iDCs was the dominant feature, whereas at the low ratio
(1:5) the same NK cells promoted iDCs survival compared
with iDCs alone over the same period (Fig. 3 A). The equal
ratio of NK/DC (1:1) fell between these two extremes. The
NK cell–mediated lysis of the K562 targets increased at all
ratios tested after the 24-h incubation. These striking differ-
ences between death and survival of DCs upon encounter-
ing NK cells correlate precisely with our previous results on
TNF-
 
 
 
 and IL-12 p40 production where increasing num-
bers of NK cells in the culture shifts the NK effect from po-
tent stimulation to complete inhibition (Fig. 2).
NK cells can both efficiently kill and potently stimulate
DCs in our model system and each of these opposing ef-
fects appear dependent on cell-to-cell contact. To quantify
these apparent cognate interactions we measured the for-
mation of NK–DC conjugates and compared them to con-
jugates formed by NK cells and tumor targets. Our analysis
revealed that NK cells bound DC (Fig. 3 C–E) with an ef-
ficiency almost equal to that of NK cell binding to the clas-
sical NK-target, K562 (Fig. 3 F–H). Binding was detectable
even at the lowest NK/DC ratio tested (1:5) indicating that
NK–DC conjugates are formed in our other experiments
measuring cytokine production and cell killing.
Our initial experiments using resting NK cells (Fig. 1)
demonstrated a contact-dependent NK effect driving iDCs
to mature. Therefore, we tested what effects activated NK
cells mediated on DC maturation (Fig. 4). Similar to our
previous results with activated NK cells (Figs. 2 and 3), ad-
dition of NK cells to the culture leads to opposing effects
on the iDC population depending on the NK/DC ratio.
Compared with the untreated DCs (Fig. 4 A–C), low
NK/DC ratios (1:5 or 1:1) consistently augmented expres-
sion of the maturation markers: CD86 (Fig. 4 D–I),
CD83, and HLA-DR (data not shown). At a 5:1 ratio
(NK/DC) most of the DCs are nonviable (Fig. 4 J–L). Ad-
dition of suboptimal doses of LPS (Fig. 4 C, F, I, and L)
augmented the NK-induced maturation at NK/DC ratios
of 1:5 and 1:1, but had no effect at the 5:1 ratio. Again,
Figure 4. Activated/cultured NK cell–mediated maturation/death of
DCs. Cultured iDCs were incubated for 48 h, alone (A–C), or with NK
cells at the following ratios (NK/DC), 1:5 (D–F), 1:1 (G–I), and 5:1 (J–
L). Forward versus side scatter plots (A, D, G, and J) show the gating on
the DC subset and demonstrate its disappearance at the 5:1 (NK/DC) ra-
tio (J). Propidium iodide staining of the NK/DC (5:1) cultures confirmed
the almost complete absence of viable DCs (data not shown). Staining for
CD86 expression was performed as described in Fig. 1 and the histo-
grams are shown for DCs cultured in the presence (C, F, I, and L) or
absence (B, E, H, and K) of 1 ng/ml of LPS. Results are representative
of six experiments performed.
Figure 5. Activated/cultured NK cell-induced DC maturation is de-
pendent on cell-to-cell contact and endogenous TNF-  production.
Cultured iDCs were incubated alone (A, D, and G); with activated NK
cells at an NK/DC ratio of 1:5 (B, E, and H); with activated NK cells
(NK/DC; 1:5) separated in trans-wells (C and F); or with activated NK
cells and 10  g/ml of a neutralizing antibody for TNF-  (I). LPS con-
centrations used were: 0 ng/ml (A–C); 10 ng/ml (D–F) and 50 ng/ml
(G–I). CD86 staining of the DC subset was performed as in Figs. 1 and 4.
Results are representative of four experiments performed. 
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DC maturation was dependent on NK cell contact and
endogenously produced TNF-
 
 
 
, because it did not occur
when the two cell types were separated in trans-wells or
upon the addition of a neutralizing antibody for TNF-
 
 
 
(Fig. 5). Moreover, addition of blocking reagents for
CD80, CD86, CD154, CD95, CD11a, CD50, IL-12,
IFN- , IFN- , or IFN-  had no effect on the NK-induced
maturation (data not shown).
Discussion
Cognate interactions are a common feature of the anti-
gen-specific immune response, where intimate cell-to-cell
contact governs such critical events as antigen presentation,
and the delivery of T cell help to CTLs and B cells (1, 3,
18–20). By contrast, coordinated control of innate immu-
nity is thought to be mediated almost exclusively by cyto-
kine feedback loops (2, 17, 21). Recently, one exception to
this general rule has been proposed for the innate immune
system and importantly, it involves contact-dependent acti-
vation of murine NK cells by iDCs (22). Consistent with
this study, we also see evidence of NK cell activation in our
system which is dependent on DC contact, although we
have not investigated the extent and nature of this NK acti-
vation in further detail.
NK cells arrive at sites of infection within minutes to
hours after pathogen invasion (4, 21, 23). Here, they
should encounter resident DCs already responding to sig-
nals derived from invading pathogens and proinflammatory
cytokines such as TNF-  (1, 3). We designed our in vitro
model to recapitulate some of the most salient features of
the early inflammatory process. This simple model cannot
reproduce many aspects of the in vivo situation where the
flow of immune cells, pathogens, and soluble factors in and
out of the inflamed tissue is a dynamic process. Neverthe-
less, using this system, we have defined two extreme out-
comes of an NK–DC encounter: (i) potent amplification
and (ii) complete inhibition. During a normal functioning
immune response, the majority of in vivo relevance of this
NK–DC “control switch” likely lies at various points be-
tween the two in vitro extremes described here. However,
it is tempting to speculate that the dramatic NK-mediated
stimulation/inhibition of TNF-  production we observe
reveals a novel positive/negative feedback loop applicable
to TNF- –mediated pathologies such as septic shock.
The inhibition of DC responses by NK cells at high NK/
DC ratios, appears simply due to NK cell–mediated cyto-
toxicity which has already been described as a potential out-
come of NK–DC encounters (11, 12). However, with the
exception of endogenous TNF-  production which is nec-
essary for NK-induced DC maturation, all other experi-
ments using blocking reagents against numerous surface
receptors and soluble factors failed to reveal a specific mech-
anism for the NK cell stimulatory effect. Although we can-
not rule out the possibility that untested receptor/ligand
pairs govern this interaction, we propose an alternative
model founded on the more general phenomenon of NK
cell killing of DCs. The model is based on the hypothesis
that the majority of NK–DC interactions are fatal for the
DCs. Thus, amplification of DC responses occurs by a by-
stander effect whereby killing of DCs by NK cells provides
the activation signal(s) for their nonNK-binding neighbors.
At low NK/DC ratios there are plenty of viable DCs to
mediate this bystander effect, whereas, at higher ratios, there
are no bystanders. This model fits nicely with our current
understanding of the heterogeneous nature of NK cell trig-
gering receptors (24) and is consistent with the results pre-
sented here. Moreover, it adds a new twist to “Stranger/
Danger” models (25–28) for the initiation/amplification of
innate immune responses. Thus, the arrival of activated NK
cells (“stranger”) into infected tissues and their killing
(“danger”) of resident DCs serves to amplify the “stranger/
danger” signals derived from invading pathogens. It will be
important to test this model with particular emphasis placed
on understanding a role (or lack thereof) for NK cell inhib-
itory/stimulatory receptors for autologous HLA class I mol-
ecules (24). Given the exquisite sensitivity of autologous
iDCs (11, 12) to NK cell cytotoxicity, it is likely that during
an NK–DC encounter the diverse families of NK cell re-
ceptors for class I function differently than they do during
encounters with more traditional target cell types.
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